Virtu Financial’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Virtu Financial's NKTR Position: Q3 2026 in Review
Virtu Financial opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 14,322 shares worth $867K. The stake represents 0.03% of the portfolio and ranks #359 among its holdings. This is a return to the name: Virtu Financial previously reported a position in NKTR as recently as Q4 2025.
Virtu Financial first reported a position in NKTR in Q3 2014 and has held it in 10 quarters since. 243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.
- Virtu Financial held 14,322 shares of Nektar Therapeutics worth $867K as of Q3 2026.
- Nektar Therapeutics was a new Virtu Financial position in Q3 2026.
- Nektar Therapeutics made up 0.03% of Virtu Financial's portfolio in Q3 2026, its #359 holding.
- Virtu Financial first reported a position in Nektar Therapeutics in Q3 2014 and has held it in 10 quarters since.
- 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.